Warning letter to a pharmacy · Center for Drug Evaluation and Research (CDER)
FDA warning letter 738238 to Empower Clinic Services, LLC dba Empower Pharmacy
Issued September 18, 2026 to a compounding pharmacy, not to a seller. 7 seller records name Empower Pharmacy as a pharmacy that fills orders, so the letter is disclosed on those records beside S3, pharmacy identification. It changes no disposition.
The letter, as filed
| Number | MARCS-CMS 738238 |
|---|---|
| Issued | September 18, 2026 |
| Addressee | Empower Clinic Services, LLC dba Empower Pharmacy |
| Address | 7601 N. Sam Houston Pkwy W., Ste. 100, Houston, TX 77064-3595 |
| Recipient | Arta Shaun Noorian, Founder & Chief Executive Officer |
| Issuing office | Center for Drug Evaluation and Research (CDER) |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug |
| Sections cited | 503A, 501(a)(2)(A), 501(a)(2)(B), 505(a), 502(f)(1), 301(a), 301(d), 301(k) of the Federal Food, Drug, and Cosmetic Act |
| Close-out letter | None on the index when this letter was added. |
What it says
The letter rests on an inspection: From November 3, 2025, through November 14, 2025
“You should take prompt action to address any violations.”
Quoted exactly as the letter prints them. The letter describes the facility on the dates of that inspection; it says nothing about any seller, and this site adds nothing to it.
How it was attributed
The letter identifies Empower Pharmacy at the same Houston street and suite printed on the pharmacy's own contact page; Empower Pharma is separately listed at another facility. The letter is tied to the pharmacy entry in this ledger's pharmacy registry, never to a seller: no seller is named in it.
Records that name this pharmacy
Each record below names the pharmacy under S3, in the seller's own words:
- Invyncible: Empower Pharmacy in Houston, Texas.
- Lavender Sky Health: Empower Pharmacy.
- Marek Health: Empower Pharmacy.
- Medi-Weightloss: Empower Pharmacy in Houston, Texas.
- PreventiveMD: Empower Pharmacy.
- Vyora Wellness: Empower RX in Houston, Texas.
- Willow: Empower Pharmacy.
What it changes on a record
Nothing in any disposition. S8, enforcement status, asks about the seller's own operating entity, and a letter to a pharmacy it names is not one. The Standard asks a seller to name its pharmacy so that a reader can look the facility up; this page is that lookup, and each record above links here from its S3 row.
Sources
- FDA warning letter 738238 to Empower Clinic Services, LLC dba Empower Pharmacy, read in full
- FDA, About Warning and Close-Out Letters
- FDA warning letter index, and its close-out column
The letter is quoted from its own page on fda.gov, as it stood on the date in the meta line above. This page ranks nothing, recommends nothing, and carries no partner link.